HOME › DRUGS › BRENSOCATIB
ACTIVE SUBSTANCE / INN

BRENSOCATIB

Brand name(s): Brinsupri, BRINSUPRI
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA217673
Bronchiectasis;Lung Diseases
ACTIVE SUBSTANCE
Brensocatib
REGULATORS
FDA · EMA
SPONSORS / MAH
INSMED INC, Insmed Netherlands B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BRINSUPRINDA217673INSMED INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BrinsupriInsmed Netherlands B.V.Authorised18/11/2025Bronchiectasis;Lung Diseases

FULL INTELLIGENCE ON BRENSOCATIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →